{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:06:56Z","timestamp":1789506416753,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012411","name":"Alborz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.carrev.2023.01.023","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T21:45:57Z","timestamp":1675115157000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion In Patients Undergoing Primary Percutaneous Coronary Intervention For ST-Elevation Myocardial Infarction"],"prefix":"10.1016","volume":"51","author":[{"given":"Mehdi","family":"Mousavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sehati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Tayebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza Dehghan","family":"Nayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Movahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2023.01.023_bb0005","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.carrev.2023.01.023_bb0010","author":"Savarese"},{"key":"10.1016\/j.carrev.2023.01.023_bb0015","series-title":"Braunwald's heart disease a textbook of cardiovascular medicine","article-title":"Percotaneous coronary intervention","author":"Mauri","year":"2018"},{"issue":"13","key":"10.1016\/j.carrev.2023.01.023_bb0020","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/01.CIR.0000031570.27023.79","volume":"106","author":"Srinivas","year":"2002","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.carrev.2023.01.023_bb0025","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"issue":"9247","key":"10.1016\/j.carrev.2023.01.023_bb0030","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial","volume":"356","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.carrev.2023.01.023_bb0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.amjcard.2014.12.031","article-title":"Effect of a shortened-duration eptifibatide infusion (75 mg) as adjunctive therapy for percutaneous coronary intervention on in-hospital cardiovascular outcomes and bleeding","volume":"115","author":"Nei","year":"2015","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.carrev.2023.01.023_bb0040","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jacc.2008.09.060","article-title":"Abbreviated infusion of eptifibatide after successful coronary intervention the BRIEF-PCI (Brief infusion of eptifibatide following percutaneous coronary Intervention) randomized trial","volume":"53","author":"Fung","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2023.01.023_bb0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ahj.2008.04.019","article-title":"Bolus-only versus bolus + infusion of glycoprotein IIb\/IIIa inhibitors during percutaneous coronary intervention","volume":"156","author":"Kini","year":"2008","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.carrev.2023.01.023_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/HPC.0000000000000079","article-title":"Comparison of 1-year major adverse cardiac events in patients undergoing primary percutaneous coronary intervention receiving intracoronary bolus only versus intracoronary bolus plus infusion of glycoprotein IIb\/IIIa inhibitors","volume":"15","author":"Kassaian","year":"2016","journal-title":"Crit Pathw Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2023.01.023_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12928-016-0418-9","article-title":"Intracoronary versus intravenous eptifibatide during percutaneous coronary intervention for acute ST-segment elevation myocardial infarction; a randomized controlled trial","volume":"32","author":"Sanati","year":"2017","journal-title":"Cardiovasc Interv Ther"},{"issue":"1","key":"10.1016\/j.carrev.2023.01.023_bb0060","first-page":"59","article-title":"Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"79","author":"K\u0131rma","year":"2012","journal-title":"Catheter CardiovascInterv"},{"issue":"11","key":"10.1016\/j.carrev.2023.01.023_bb0065","first-page":"521","article-title":"Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention","volume":"18","author":"Marmur","year":"2006","journal-title":"J Invasive Cardiol"},{"issue":"24","key":"10.1016\/j.carrev.2023.01.023_bb0070","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1161\/CIRCULATIONAHA.106.638627","article-title":"A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation","volume":"114","author":"Bertrand","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.carrev.2023.01.023_bb0075","first-page":"185","article-title":"Comparing efficacy of receiving different dosages of eptifibatide in bleeding after percutaneous coronary intervention in patients with myocardial infarction","volume":"15","author":"Shemirani","year":"2019","journal-title":"ARYA Atherosclerosis"},{"issue":"24","key":"10.1016\/j.carrev.2023.01.023_bb0080","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the academic research Consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carrev.2023.01.023_bb0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2007.09.053","article-title":"The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention","volume":"51","author":"Gurm","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2023.01.023_bb0090","first-page":"246","article-title":"Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS","volume":"2","author":"Hess","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:26:27Z","timestamp":1761560787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838923000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":18,"alternative-id":["S1553838923000258"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2023.01.023","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Double-Blinded Randomized Controlled Trial Comparing Eptifibatide Bolus Only Versus Bolus Plus Infusion In Patients Undergoing Primary Percutaneous Coronary Intervention For ST-Elevation Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2023.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}